MODERATORS: Kenneth Hornbuckle | Marie Louise De Bruin
Benefit-Risk Assessment to Support the FDA’s Decision on Vaccines for SARS-CoV-2
Hong Yang (United States)
Rethinking Survey Samples in Patient Preference Studies: A First-Degree Relative Sample Versus a General Public Proxy Sample in Rheumatoid Arthritis Prevention
Rachael DiSantostefano | Gwenda Simons | Matthias Englbrecht | Jennifer Humphreys | Ian Bruce | Karin Schölin Bywall | Christine Radawski | Karim Raza | Marie Falahee | Jorien Veldwijk (United States)
Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates
Shahab Abtahi | Romin Pajouheshnia | Carlos Durán | Judit Riera-Arnau | Miriam Sturkenboom | Olaf Klungel (Netherlands)
Prenatal Exposure to Valproic Acid in the United States 
Nicole Smolinski | Amir Sarayani | Thuy Thai | Sebastian Jugl | Celeste Ewig | Almut Winterstein (United States)
Assessment of the Effectiveness of Risk Evaluation and Mitigation Strategy for the Prevention of Fetal Exposure to Phentermine-Topiramate Using Two Large Nationwide Cohorts 
Yanmin Zhu | Sonia Hernandez-Diaz | Priyanka Anand | Katsiaryna Bykov | Ameet Sarpatwari | Mufaddal Mahesri | Elyse Dicesare | Seanna Vine | Helen Mogun | Krista Huybrechts
(United States)
A Descriptive Observational Cohort Study to Assess Effectiveness of Risk Minimization Activities in Baricitinib Incident Users Treated for Rheumatoid Arthritis in Nordic Countries 
Marius Flege | Mikkel Ankarfeldt | Aleksander Søltoft-Jensen | Karoline Doser | Eero Pukkala | Kristian Bolin | Janne Petersen | Espen Jimenez-Solem (Denmark)